2019 Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 61 pages | ID: 220499C141FEN
VPAResearch

Abstracts

The global clinical trial report- “2019 Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Corrosive Esophagitis (Erosive Esophagitis). It presents in-depth analysis of Corrosive Esophagitis (Erosive Esophagitis) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Corrosive Esophagitis (Erosive Esophagitis).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Corrosive Esophagitis (Erosive Esophagitis) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Corrosive Esophagitis (Erosive Esophagitis)

The research work is prepared through extensive and continuous research on Corrosive Esophagitis (Erosive Esophagitis) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Corrosive Esophagitis (Erosive Esophagitis) patients are identified
• The report includes panorama of Corrosive Esophagitis (Erosive Esophagitis) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Corrosive Esophagitis (Erosive Esophagitis) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials by Region
  2.2.2 Average Enrollment of Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Corrosive Esophagitis (Erosive Esophagitis) Treatment, 2019

3. REGION WISE CORROSIVE ESOPHAGITIS (EROSIVE ESOPHAGITIS) CLINICAL TRIALS

3.1 Asia Pacific Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials by Country
3.2 Europe Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials by Country
3.3 North America Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials by Country
3.4 Middle East and Africa Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials by Country
3.5 South and Central America Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials by Country

4. CORROSIVE ESOPHAGITIS (EROSIVE ESOPHAGITIS) CLINICAL TRIAL TRENDS

4.1 Start Year wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials
4.2 Phase wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials
4.3 Trial Status wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials
4.4 Trial Type wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials

5. CORROSIVE ESOPHAGITIS (EROSIVE ESOPHAGITIS) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Corrosive Esophagitis (Erosive Esophagitis) Trials by Year
5.2 Average Enrollment in Corrosive Esophagitis (Erosive Esophagitis) Trials by Phase
5.3 Average Enrollment in Corrosive Esophagitis (Erosive Esophagitis) Trials by Status
5.4 Average Enrollment in Corrosive Esophagitis (Erosive Esophagitis) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN CORROSIVE ESOPHAGITIS (EROSIVE ESOPHAGITIS) CLINICAL TRIALS

6.1 Corrosive Esophagitis (Erosive Esophagitis) Trials by Sponsor Type
6.2 Corrosive Esophagitis (Erosive Esophagitis) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Corrosive Esophagitis (Erosive Esophagitis) Trials- Phase
7.2 Corrosive Esophagitis (Erosive Esophagitis) Trials- Phase
7.3 Corrosive Esophagitis (Erosive Esophagitis) Trials- Phase
7.4 Corrosive Esophagitis (Erosive Esophagitis) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials and Enrolment
Figure 7: North America – Country wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials and Enrolment
Figure 9: Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials by Phase
Figure 10: Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials by Trial Status
Figure 11: Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials by Type
Figure 12: Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials by Sponsor Type
Figure 13: Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials by Leading Sponsors
Figure 14: Corrosive Esophagitis (Erosive Esophagitis) Average Enrollment by Phase
Figure 15: Corrosive Esophagitis (Erosive Esophagitis) Average Enrollment by Trial Status
Figure 16: Corrosive Esophagitis (Erosive Esophagitis) Average Enrollment by Type
Figure 17: Corrosive Esophagitis (Erosive Esophagitis)- Average Enrolment by Type of Sponsors
Figure 18: Corrosive Esophagitis (Erosive Esophagitis)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials and Enrolment
Table 5: Europe – Country wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials and Enrolment
Table 7: North America – Country wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Corrosive Esophagitis (Erosive Esophagitis) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Corrosive Esophagitis (Erosive Esophagitis) Average Enrollment by Phase
Table 15: Corrosive Esophagitis (Erosive Esophagitis) Average Enrollment by Trial Status
Table 16: Corrosive Esophagitis (Erosive Esophagitis) Average Enrollment by Type
Table 17: Corrosive Esophagitis (Erosive Esophagitis)- Average Enrolment by Type of Sponsors
Table 18: Corrosive Esophagitis (Erosive Esophagitis)- Enrolment by Leading Sponsors